Cooper Companies director buys $539,150 in stock
Alpha Vantage · Investing.com · · AI-summarised by FinFlash
Cooper Companies director Lawrence Erik Kurzius bought 10,000 shares of the medical device maker's common stock for $539,150, at $53.915 per share. The purchase is seen as strategically timed given the stock's undervaluation and management's aggressive buyback program. It follows mixed analyst reactions to Q3 fiscal 2026 earnings, with some firms cutting price targets while others kept positive ratings.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.